Grigoris Karamasis

Interventional Cardiologist, Attikon University Hospital

[Dr Sarosh Khan @dr_skhan1]

ORBITA-CTO will be presented in... 55 minutes time. #Acc26 @EssexCTC

[Dr Thomas Keeble @DrKeeble]

A superb educational live case of bolus and continuous thermodilution and spasm provocation - congratulations @Dizzledavies73 @kliokon @MSEResearchTeam @EssexCTC @EssexCTC_Cardio @MSEssex_ICS

[Grigoris Karamasis @grkaramasis]

Intracoronary Imaging and Physiology Course 2025 Edition, 15th February 2025, Stavros Niarchos Foundation Cultural Centre, Athens, Greece
1-day course on Intracoronary Imaging and Physiology featuring case-based discussion, expert lectures, cases-in-a-box and hands-on workshops.

[Dr Thomas Keeble @DrKeeble]

It's a lovely review @JEscaned . Proud that the last 5 manuscripts included are all from our @EssexCTC @MSEResearchTeam clinical trial with Eindhoven and Brighton. ORBITA CTO pilot study coming soon....@Dizzledavies73 @dr_skhan1 @rallamee

[Ozan Demir @DrOzanDemir]

Accuracy of PW–Derived Indices in LMCA Disease @JACCJournals

🔗 https://t.co/HpLlraXWmH

➡️FFR superior to NHPRs at detecting significant LMCA disease

➡️Discordance rates: iFR 18.1% and Pd/Pa 17.0%, primarily due to false negatives

@TheBHF @kingscardio @PCRonline @ACCinTouch

[Cardiac Research @UKheartresearch]

In LMCA Disease FFR is superior to NHPRs at detecting significant LMCA disease

Clinically significant discordance with NHPRs

🔗 https://t.co/MfvQmeE20k

@DFCapodanno @DrKeeble @habib_samady @wfearonmd @MauroEchavPinto @DamienCollison @ColletCarlos @mmamas1973 @profcolinberry

[Dr Thomas Keeble @DrKeeble]

Really looking forward to TCT. @EssexCTC @MSEResearchTeam lots to learn and discuss. @DrTonyYoung @Craftytracey

[Dr Thomas Keeble @DrKeeble]

We hope to have the results of the ORBITA CTO pilot study next year to understand the placebo effect in blinded CTO PCI. @dr_skhan1 @rallamee @Dizzledavies73

[Sotiria Liori @SotiriaLiori]

Kick-starting the new academic year at Attikon Hospital! Let’s dive into recent heart failure trials with highlights from ESC 2024, where RESHAPE-HF2 and FINEARTS-HF were presented, and simultaneously published in NEJM, with our chair and my mentor, @Filippatos playing key roles.

🔹 RESHAPE-HF2:

- M-TEER with MitraClip reduced CV death and HF hospitalizations 🏥 by 41% over 24 months
- Greater benefits seen in patients with recent HF hospitalizations ⏳ (n=505)

🔹 FINEARTS-HF:

- Finerenone in HFpEF (EF ≥40%) reduced worsening HF events and CV death by 18%
- Included 6,001 patients with significant quality of life improvements and low hyperkalemia risk 🧪

#HeartFailure #RESHAPEHF2 #FINEARTSHF #ESC2024 #HFAYoung

[FRANCESCO BURZOTTA @BURZOTTA_F]

We like to find what we believe. My #cathlab highlights from #CAD 2024 European GL:
#radialfirst Class 1A: the end of ‘femoralists”!
#FFR Class 1A in intermediate lesions: the end of 1 angio=1 stent!
#IVUS/#OCT Class 1A for complex #PCI : the end of ‘I don’t need imaging’ guys!

[Rafail Kotronias @RafKotronias]

After validating IMRangio against bolus thermodilution IMR, we explore the first non-invasive, angiographic, pressure-wire and microcatheter free method to quantify absolute coronary flow and resistance @GiovanniLuigiD1 @DrKeeble @OxAMI_Study @RDMOxford

https://t.co/L2GuC74Hvf

[Dr Thomas Keeble @DrKeeble]

Incredibly proud of the @EssexCTC @MSEResearchTeam at EuroPCR. @kliokon & PCR got talent finalist @drR_Simpson. Presentations from @DrS_Fawaz @uxmsajjad. Chaired sessions by @CCook_MD @DrOzanDemir @Dizzledavies73 @dr_skhan1 Incredible team.

[Dr Thomas Keeble @DrKeeble]

@EssexCTC presentations at @PCRonline
#EuroPCR today. #physiology #OHCA #CHIP @CCook_MD @Dizzledavies73 @dr_skhan1 @kliokon @drR_Simpson @DrS_Fawaz @drjasondungu @savodoc @MTRC_ARU @uxmsajjad @MedCrisis

[Dr Sarosh Khan @dr_skhan1]

Excited for the latest edition of #EuroPCR! Great few days of learning ahead and delighted to be presenting our work from @EssexCTC @MSEHospitals....and it begins!

[Dr Thomas Keeble @DrKeeble]

Best place for Cath lab based research in the UK. Amazing Cath lab team, research and management support @MSEResearchTeam @MSEssex_ICS @EssexCTC @essexheartfund @MSEHospitals

[Dr Thomas Keeble @DrKeeble]

https://t.co/s8kWP748wD

We have 2 fully funded interventional MD fellow posts up for grabs starting 2024. Coro physiology / CHIP. Please DM for a chat. @rallamee @MedCrisis @CCook_MD @grkaramasis @NickCurzen @divaka_perera @Ryvetsprog @DrPaulRees @DrNileshPareek @Dizzledavies73

[Gianluca Campo @GianlucaCampo78]

What's after the @theFIRE_trial ?take few minutes to see thh website of our reeearch group... https://t.co/NSW0cKYbTW

[Dr Thomas Keeble @DrKeeble]

The best physiology course on the planet. A must attend in 2024 as absolute flow, angio derived indices, live cases and incredible hands on. Can't wait @Dizzledavies73 @rallamee @ColletCarlos @divaka_perera

[John Davies @Dizzledavies73]

@MichaelMegalyMD @RhianEDavies1 @crfheart Nice to see our study from the mighty Essex Cardiothoracic Centre, UK in your four favourite slides. Thanks!

[Michael Megaly @MichaelMegalyMD]

4/5 (Khan et al. 2023)
3 months after CTO PCI, absolute coronary flow improved (30%), and microvascular resistance decreased (16%).
Biggest change was in prior CABG and high eGFR. Smallest change was when extraplaque technique is used (Food for thought!)
#CTO2024